Skip to main content
. 2023 Jun 22;61:102052. doi: 10.1016/j.eclinm.2023.102052

Fig. 3.

Fig. 3

Effectiveness outcomes of Hybrid Ablation (HA, blue) and Catheter Ablation (CA, gray) off new/increase dose previously failed Class I or III anti-arrhythmic drugs (AADs) in the persistent and longstanding persistent atrial fibrillation (LSPAF) subgroups. Relative benefit increase is the ratio of the absolute benefit increase (the difference in success percentage between the HA and CA groups) and the CA group success percentage. P-values reflect Fisher’s exact test. CI: confidence interval.